Strattera (atomoxetine) has been used for the treatment of attention-deficit hyperactivity disorder (ADHD) for a number of years. It’s sometimes used off-label for ADHD treatment in conjunction with stimulant medications and has a few off-label uses that are more common than they are. While Strattera can help reduce hyperactivity, its side effects are less common. It is not approved for ADHD treatment.
Strattera, also known as atomoxetine, is an antidepressant. It is prescribed for children, adolescents and adults with ADHD. The main indications are hyperactivity and impulsivity, which are also commonly used off-label to treat ADHD.
This article is intended to give you information about Strattera. If you have any questions about why it has been prescribed, or would like to learn more about why it has been prescribed, please talk with your doctor or pharmacist.
As with all medications, there are possible side effects. The most common side effects are nausea, vomiting, diarrhea, drowsiness, insomnia, dry mouth, headache, constipation, dizziness, and fatigue. These side effects usually go away as your body gets used to the medication.
Serious side effects that should be reported to your doctor and discussed with your healthcare provider include:
As with other medications, Strattera may cause your body to become accustomed to certain foods. The Food and Drug Administration has approved Strattera to treat ADHD. Strattera should be used only as prescribed by your doctor and not as a standalone treatment. Your doctor may also prescribe it as an adjunct to other therapies to help manage your ADHD symptoms. Strattera can be used as part of an ADHD treatment plan.
Your doctor will consider your ADHD symptoms and other medical conditions such as heart disease, liver or kidney problems, high blood pressure, and smoking. Your doctor may also consider the dose of Strattera you need, as well as other medications you are taking. Your doctor may also consider a dosage and frequency of Strattera, as well as whether Strattera is a first-line treatment for you.
This article will help you learn more about Strattera and its uses and benefits. You should also know that Strattera is a prescription medicine and should only be used under the guidance of a doctor. If you have questions about how to use Strattera safely, talk with your doctor or pharmacist.
Strattera and stimulant medications are two different drugs that are commonly used for the treatment of ADHD. Stimulants are medications that increase or decrease the activity of certain neurotransmitters in the brain.
Strattera and stimulant medications work by acting on chemicals in the brain that affect attention and behavior.
Stimulant medications work by increasing the activity of certain neurotransmitters in the brain, and increase the amount of their reuptake. These neurotransmitters are neurotransmitter receptors that are associated with attention and behavior. Stimulants are generally used to treat ADHD. Stimulants can be used off-label to treat ADHD. Strattera may be used to treat ADHD in people with ADHD or other conditions that are not treatable.
The most common side effect of Strattera is drowsiness. Strattera may also cause drowsiness. People who are unable to stay awake or stay asleep may also be sleepy. This is usually temporary and may be resolved with the use of sleep aids. However, some people may experience increased drowsiness while taking Strattera. It is not uncommon for people to experience drowsiness from taking Strattera.
Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is available.
Theannoys quickly (in both safety relief and treatment safety) for therapeutic effects from atomoxetine, unlike other non-stimulant medications that require a short-term regimen to work.
Strattera is an oral selective serotonin reuptake inhibitor (SSRI) that provides immediate, short-term relief from symptoms of depression, anxiety disorders, and insomnia. Unlike selective serotonin reuptake inhibitors that take weeks to treat the symptoms, Strattera andossible weeks, however, are not required by the brand-name drug to be effective.
These SSRIs are commonly prescribed for their anti-epileptic properties. They are often the first-line treatment for the symptoms of generalized anxiety disorder, major depressive disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder. Strattera is approved for treatment of obsessive-compulsive disorder as well as depression, as well as other conditions that cause excessive fear of unattended things.
OCD is a condition when body-wide serotonin is low, resulting from excessive worry. Strattera helps to reduce this too, and is not recommended to treat obsessive-compulsive disorder or panic. However, patients may be treated with a one-week, non-addictive periodontal treatment.
Strattera is an effective short-term treatment for patients with obsessive-compulsive disorder and severe to moderate obsessive-compulsive disorder. However, it is not recommended to treat bipolar mania or treat mania with lithium or antipsychotics. For additional advice regarding obsessive-compulsive disorder,andin particular, and other conditions,.
As a non-stimulant treatment, Strattera should be taken at a dose of 10 mg once or twice daily, not once per day. The usual starting dose for adults is 10 mg, divided into 1 or 2 divided doses. A starting dose of 30 mg is commonly prescribed for the treatment of patients ages 18 to 64. A starting dose of 5 mg is typically prescribed for the treatment of patients who do not respond to one or the other of Strattera's oral SSRIs.
When starting treatment for obsessive-compulsive disorder, dose levels should be determined by the patient based on their response and specific condition. For patients who find them to be the most effective way to treat their obsessive-compulsive disorder, dose levels may vary. Therefore, a starting dose of 10 mg to 20 mg should be prescribed, and the balance maintained. For maintenance treatment, a dose of 30 mg to 40 mg is recommended, and the doses spares and ills may be prescribed. For specific medication considerations,are important. Strattera is generally not recommended to be used in patients who have taken a high dose of lithium or antipsychotics before the use of the oral SSRI. In clinical practice, it is generally best to start with a lower dose of the drug, and adjust based on the patient's response to the treatment.
Some of the most common Strattera side effects are headache, dry mouth, insomnia, dizziness, drowsiness, constipation, and weakness. More serious side effects are rare, but may occur, and should be carefully monitored by the patient. If they are experienced by less than 2% of the patients prescribed Strattera, they should be discontinued the occurrence of which they have experienced since the last dose was released.
Adolescents are more likely to experience side effects from Strattera in the absence of adverse reactions to: PDE5i,or any other substance, as it affects the heart and nervous system, particularly with certain medications. Since it is primarily a medication used to treat depression, adolescents may be treated with Strattera once per day for a specific number of days per academic year (AYA).
Strattera is not suitable for everyone, particularly those with certain mental health conditions. Talk to your health care provider if you have any concerns.
Recently, we learned that Strattera may be unavailable in the United States.
One potential explanation for this could be a decrease in the amount of norepinephrine in the brain.
A small study published in theArchives of Internal Medicinefound that Strattera was less effective in treating attention deficit hyperactivity disorder than placebo and methylphenidate.
The recommended starting dose for Strattera is 10 mg once daily. This may be adjusted based on the condition being treated and the severity of the patient’s symptoms.
If the 10 mg dose is insufficient, your doctor may increase your dosage to 20 mg once daily. This dosage may be used for as long as 10 years.
Take Strattera exactly as prescribed by your doctor. Swallow the tablet whole with a glass of water. Do not chew or crush the tablet. Strattera should be taken with or without food.
If you miss a dose, take it as soon as you remember. If it’s close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take 2 doses at once.
Most Strattera side effects are mild, but they can be serious. The most common side effects include:
Less serious side effects, such as increased appetite, vomiting, and drowsiness, are more likely with higher doses or longer dosing.
You can buy Strattera online from eDrugstore, a longtime online pharmacy based in Tempe, Arizona. It sells generic versions of the drug. To learn more, visit its.
We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners, and health educators.
If you have a medical condition or questions about this product, please contact our toll-free customer support hotline (1-866-225-0olyn-a), by phone or email:or we can answer your questions. You can also report side effects or make a special payment.We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our main camera and hard drive encryption service.We're open Monday to Friday 8:00 a.m. to 5:00 p.m. and 5:00 p.m. to 9:00 a.m. Expect to make one payment per 15 business days after the rest of the product's packaging is shipped.
Atomoxetine/Synthroid:Treatment of attention-deficit hyperactivity disorder (ADHD) and mixed-type-anxiety disorder (MDAD).Strattera/Tenormin:In combination with other stimulants to enhance response.
Strattera/Synthroid:
Treatment of ADHD, but also used for combination therapy with stimulants and other antidepressants.Tricyte/Strattera:Tunarx:In combination with other stimulants and other antidepressants.Tenormin/Strattera:Strattera:Synthroid:Adults user with ADHD and/or depression. Treatment of anxiety disorders.
In combination with other antidepressants.Tenormin:Therapeutic effect: an antidepressant. Pharmacologic classification: Selective serotonin reuptake inhibitor (SSRI) drug.
None should be used with consideration to clinical circumstances, particularly in patients who have had a recent stroke, transient global amnesia (myocardial infarction within 2 hours ofLLOW- amocard). Interactions: Keep out of reach of children and adolescents. Drug interaction: Keep atomoxetine/synthroid together and in close proximity of it. Taking it while you are using it can cause your blood sugar to beeto greater than 3 units lower than normal. This can be dangerous and can lead to a dangerous fall in blood sugar. Keep out of reach of children and adolescents. Drug interactions (including drug interactions) with other drugs: KeepStrattera/Synthroid together.
Athletes/ocumented examination/examining of their athletes/ocumented examination of their bodies (e.g., blood count, chemistry) for possible drug interactions should consider the following: Concerns (e.g., may my athlete become dependent on Strattera/Synthroid). Dependence and dependence and potential effects on drug metabolism. Safety and potential effects on health. Monitor and adjust as needed to monitor the athlete and body. This is not a complete list of drug interactions. Ask your health care provider about other drugs or supplements that may interact. Dependence may not be reversible. You may want to try other ways to manage it (e.g., exercise, diet, weight loss). If drug interactions do occur, notify your health care provider immediately.
The most common adverse reactions (≥1%) reported in association with atomoxetine/synthroid use include:allergic reactions: 1 patient had severe sedation and coma, which required intubation. The following patients also experienced side effects:rash: 1 patient had difficulty breathing, 2 had difficulty swallowing, 3 had difficulty moving their tongue, 4 had difficulty moving their fingers, 5 had difficulty closing their eyes, 6 had difficulty moving their feet. The following patients also experienced effects:hypotension: 1 patient had hypokalemia and 1 had hyperglycemia. The following patients experienced effects:tremor: 1 patient had tardive dyskinesia and 1 had spasm.
Stade de France Pharmacy